BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37596842)

  • 1. RB1 loss in the mesenchymal component of onychomatricoma.
    Liu Y; Zou D; Huang Q; Wang L
    J Cutan Pathol; 2023 Dec; 50(12):1094-1098. PubMed ID: 37596842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
    Perrin C; Pedeutour F; Coutts M; Ambrosetti D; Dadone-Montaudié B
    Histopathology; 2023 Apr; 82(5):767-778. PubMed ID: 36647795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions.
    Agaimy A; Michal M; Giedl J; Hadravsky L; Michal M
    Hum Pathol; 2017 Feb; 60():192-198. PubMed ID: 27825811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onychomatricoma: genome-wide analyses of a rare nail matrix tumor.
    Cañueto J; Santos-Briz Á; García JL; Robledo C; Unamuno P
    J Am Acad Dermatol; 2011 Mar; 64(3):573-8, 578.e1. PubMed ID: 20691500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker.
    Motanagh S; Bridge JA; Linos K
    J Cutan Pathol; 2021 Feb; 48(2):295-301. PubMed ID: 32524651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of onychomatricoma with minimally invasive surgical procedures based on its pathogenesis: A case report.
    Miyamoto J; Kawashima Y; Hayakawa M; Fusumae T; Yoshida T; Saito M
    J Dermatol; 2024 May; 51(5):719-721. PubMed ID: 38212937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomatricoma Presenting as a Dystrophic Right Great Toenail: Case Report and Review.
    Romero LS; Park H; Shoaee N; Cohen PR
    Cureus; 2020 May; 12(5):e7946. PubMed ID: 32499986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid onychomatricoma: an unusual variant of a rare nail unit tumor.
    Stewart CL; Sobanko JF; Rubin AI
    Am J Dermatopathol; 2015 Jun; 37(6):473-6. PubMed ID: 25830718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychomatricoma: clinical and histopathologic findings in 12 cases.
    Perrin C; Goettmann S; Baran R
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):560-4. PubMed ID: 9777762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Onychomatricoma, a rare lesion of the nail].
    Pommepuy I; Roblet D; Blaise S; Delage-Corre M; Bonnetblanc JM; Fayol J; Labrousse F
    Ann Pathol; 2004 Sep; 24(4):368-70. PubMed ID: 15567955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The onychomatricoma: additional histologic criteria and immunohistochemical study.
    Perrin C; Baran R; Pisani A; Ortonne JP; Michiels JF
    Am J Dermatopathol; 2002 Jun; 24(3):199-203. PubMed ID: 12140434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomatricoma has channel-like structures on in vivo reflectance confocal microscopy.
    Sanchez M; Hu S; Miteva M; Tosti A
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1560-2. PubMed ID: 24112758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroepithelial Stromal Polyp of the Vulvovaginal Region as Part of the RB1 Family of Tumors: Friend or Foe?
    Cordier F; Van Roy N; Matthys B; De Paepe P; Van de Vijver K; Van Dorpe J; Creytens D
    Int J Gynecol Pathol; 2024 May; 43(3):215-220. PubMed ID: 37922949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomatricoma is not a subtype of superficial acral fibromyxoma: Can immunohistochemistry help in the differential diagnosis?
    Perrin C; Coutts M
    J Cutan Pathol; 2024 Jun; 51(6):439-440. PubMed ID: 38527773
    [No Abstract]   [Full Text] [Related]  

  • 15. Myxoid Onychomatricoma-A New Case.
    Pessoa E Costa T; João AL; Pinheiro R; Carvalho R; Matos Pires E; Lencastre A
    Am J Dermatopathol; 2020 Feb; 42(2):133-135. PubMed ID: 31503009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomatricoma: new clinical and histological features. A review of 19 tumors.
    Perrin C; Baran R; Balaguer T; Chignon-Sicard B; Cannata GE; Petrella T; Michiels JF
    Am J Dermatopathol; 2010 Feb; 32(1):1-8. PubMed ID: 20098079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nail bed onychomatricoma.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2014 Oct; 41(10):783-6. PubMed ID: 25039855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomatricoma: A Rare and Potentially Underreported Tumor of the Nail Matrix.
    Rushing CJ; Ivankiv R; Bullock NM; Rogers DE; Spinner SM
    J Foot Ankle Surg; 2017; 56(5):1095-1098. PubMed ID: 28558997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant onychomatricoma: report of two cases with rare clinical presentation.
    Estrada-Chavez G; Vega-Memije ME; Toussaint-Caire S; Rangel L; Dominguez-Cherit J
    Int J Dermatol; 2007 Jun; 46(6):634-6. PubMed ID: 17550569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating Onychomatricoma. Clinical, Dermoscopical, and Pathologic Features of Onychomatricoma New Variant Resembling Onycholemmal/Squamous Cell Carcinoma.
    Perrin C; Ambrosetti D; Balme B; Thomas L
    Am J Dermatopathol; 2020 Nov; 42(11):827-834. PubMed ID: 32271204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.